Kovitz Investment Group Partners LLC purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 8,245 shares of the company's stock, valued at approximately $1,343,000.
Several other large investors have also bought and sold shares of the stock. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the third quarter worth about $27,000. Innealta Capital LLC bought a new position in shares of Clorox during the second quarter valued at approximately $30,000. Trifecta Capital Advisors LLC grew its stake in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after purchasing an additional 130 shares during the period. Family Firm Inc. purchased a new stake in Clorox in the second quarter worth $31,000. Finally, Quarry LP grew its stake in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares during the period. 78.53% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
CLX has been the subject of several recent analyst reports. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and upped their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and increased their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. BNP Paribas upgraded Clorox to a "strong sell" rating in a research report on Friday, September 6th. Finally, DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Clorox currently has an average rating of "Hold" and a consensus price target of $155.00.
Check Out Our Latest Research Report on CLX
Clorox Stock Down 1.8 %
Shares of NYSE:CLX traded down $3.01 during midday trading on Wednesday, hitting $164.65. 1,240,501 shares of the company's stock traded hands, compared to its average volume of 1,232,255. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a market cap of $20.38 billion, a PE ratio of 57.35, a P/E/G ratio of 3.08 and a beta of 0.42. The firm's fifty day moving average price is $163.63 and its two-hundred day moving average price is $151.12. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm's quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 EPS. On average, equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.96%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is 170.04%.
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.